Literature DB >> 19070379

Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension.

Stefano Ghio1, Catherine Klersy, Giulia Magrini, Andrea Maria D'Armini, Laura Scelsi, Claudia Raineri, Michele Pasotti, Alessandra Serio, Carlo Campana, Mario Viganò.   

Abstract

BACKGROUND: In patients with idiopathic pulmonary hypertension (IPAH) progression of the disease and survival are related to the capability of the right ventricle to adapt to the chronically elevated pulmonary artery pressure. Although several echocardiographic variables have been associated with outcome in previous studies, a comparative evaluation of all right ventricular (RV) function indices obtainable at echocardiography has never been performed.
METHODS: 59 patients consecutively admitted in a tertiary referral centre because of IPAH (22 males, mean age 46.3+/-16.1 years, 68% in WHO class III/IV at referral) underwent right heart catheterization and echocardiography. During a median follow-up period of 52 months, 21 patients died and 2 underwent lung transplantation in emergency conditions.
RESULTS: The following parameters were associated with survival: tricuspid annular plane systolic excursion (TAPSE), RV fractional area change, degree of tricuspid regurgitation, inferior vena cava collapsibility, superior vena cava flow velocity pattern, left ventricular diastolic eccentricity index. Patients with TAPSE<or=15 mm and left ventricular eccentricity index >or=1.7 had the highest event rate (51.7 per 100 person year); patients with TAPSE>15 mm and mild or no tricuspid regurgitation had the lowest event rate (2.6 per 100 person year).
CONCLUSIONS: A comprehensive echocardiographic assessment of RV systolic and diastolic function based on TAPSE, left ventricular diastolic eccentricity index and degree of tricuspid regurgitation allows an accurate prognostic stratification of patients with IPAH. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 19070379     DOI: 10.1016/j.ijcard.2008.11.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  97 in total

1.  Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension.

Authors:  Gabriela Querejeta Roca; Patricia Campbell; Brian Claggett; Ali Vazir; Debbie Quinn; Scott D Solomon; Amil M Shah
Journal:  Eur J Heart Fail       Date:  2014-11-04       Impact factor: 15.534

2.  Prognostic utility of right atrial emptying fractions in pulmonary arterial hypertension.

Authors:  Nathan W Brunner; Francois Haddad; Yukari Kobayashi; Andrew Hsi; John R Swiston; Kenneth G Gin; Roham T Zamanian
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

3.  Simple prediction of right ventricular ejection fraction using tricuspid annular plane systolic excursion in pulmonary hypertension.

Authors:  Takahiro Sato; Ichizo Tsujino; Noriko Oyama-Manabe; Hiroshi Ohira; Yoichi M Ito; Hiroyuki Sugimori; Asuka Yamada; Chisa Takashina; Taku Watanabe; Masaharu Nishimura
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-04       Impact factor: 2.357

Review 4.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 5.  Transthoracic echocardiography in the evaluation of pediatric pulmonary hypertension and ventricular dysfunction.

Authors:  Martin Koestenberger; Mark K Friedberg; Eirik Nestaas; Ina Michel-Behnke; Georg Hansmann
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

6.  Vorticity is a marker of diastolic ventricular interdependency in pulmonary hypertension.

Authors:  Michal Schäfer; James Browning; Joyce D Schroeder; Robin Shandas; Vitaly O Kheyfets; J Kern Buckner; Kendall S Hunter; Jean R Hertzberg; Brett E Fenster
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

7.  Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.

Authors:  Amil M Shah; Patricia Campbell; Gabriela Querejeta Rocha; Andrew Peacock; Robyn J Barst; Debbie Quinn; Scott D Solomon
Journal:  Eur Heart J       Date:  2014-02-23       Impact factor: 29.983

Review 8.  The role of imaging in pulmonary hypertension.

Authors:  Meenal Sharma; Andrew T Burns; Kelvin Yap; David L Prior
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

9.  Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Kotaro Nochioka; Gabriela Querejeta Roca; Brian Claggett; Tor Biering-Sørensen; Kunihiro Matsushita; Chung-Lieh Hung; Scott D Solomon; Dalane Kitzman; Amil M Shah
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

Review 10.  Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature.

Authors:  Alessandro Bellofiore; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.